Kronik lenfositik lösemili olgularımızın klinik özellikleri ve sürvisi
Loading...
Date
1993-05-13
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Uludağ Üniversitesi
Abstract
20 erkek ve 15 kadın olgu incelenmiştir (ortalama yaş 58.69 + 1.71). Tanı konulduğu anda RAİ evrelendirme sistemine göre 2 olgu evre 0,4 olgu evre 1, 8 olgu evre ll, 15 olgu evre III ve 6 olgu evre IV'e girmiştir. Exitus nedeni tespit edilebilen 10 hastada ölüm nedeni olarak 1. sıklıkla enfeksiyon, 2. sıklıkla serebral kanama gelmektedir. Bu 10 hastadan 1'i evre ll, 7'si evre lll ve 2'si evre IV'e girmekte olup, tüm hastalar için ortalama sürvi 18.5 + 5.5 ay, sadece evre lll dikkate alındığında ise 22.7 + 5.9 ay bulunmuştur. Halen takip etmekte olduğumuz 18 olguda ortalama takip süremiz 19.9 ay olup, en uzun takip süremiz ll yıldır. Tüm olgulardan 10'u kaybedildi. Ölüm sebebi ilk sırada enfeksiyon, 2. sırada beyin kanamasıydı.
Case of twenty male and fifteen female subjects with chronic lymphocytic leukemia have been examined. Having been diagnosed, in accordance with RAl stage evaluation system, two of the cases were observed to have developed stage o, four of the cases stage I, eight of the cases stage Il, fifteen of the cases stage III and six of the cases stage Ten of the all subjects died. That resulted from primarily infection and secondly cerebral bleeding. One of the above mentioned ten subjects was involved in stage ll, Seven in stage lll and two in stage IV.. The survival period of all the subjects was taken into consideration, it amounted to 22.7 + 5.9 months. The eighteen subjects who lıave survival have still been followed up. Their average survival period was 19.9 months. The longest follow-up period has been 11 years.
Case of twenty male and fifteen female subjects with chronic lymphocytic leukemia have been examined. Having been diagnosed, in accordance with RAl stage evaluation system, two of the cases were observed to have developed stage o, four of the cases stage I, eight of the cases stage Il, fifteen of the cases stage III and six of the cases stage Ten of the all subjects died. That resulted from primarily infection and secondly cerebral bleeding. One of the above mentioned ten subjects was involved in stage ll, Seven in stage lll and two in stage IV.. The survival period of all the subjects was taken into consideration, it amounted to 22.7 + 5.9 months. The eighteen subjects who lıave survival have still been followed up. Their average survival period was 19.9 months. The longest follow-up period has been 11 years.
Description
XXII. Ulusal Hematoloji Kongresinde tebliğ edildi. 21-25 Ekim 1991, İstanbul.
Keywords
Kronik lenfositik lösemi, RAİ, Survi, Chronic lymphocytic leukeamia, RAl, Survey
Citation
Tunalı, A. vd. (1993). ''Kronik lenfositik lösemili olgularımızın klinik özellikleri ve sürvisi''. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 20(1), 63-65.